Suchergebnisse - (Person:"Liu, Geoffrey")

PubPharm (21)

1

Brigatinib vs alectinib in crizotinib-resistant advanced anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALTA-3)

enthalten in: Future oncology (London, England) | 2021

von Popat, S. | Liu, G. | Lu, S. | +3

2

First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer

enthalten in: The New England journal of medicine | 2020

von Shaw, A. | Bauer, T. | de Marinis, F. | +112

CommentIn: Nat Rev Clin Oncol. 2021 Jan;18(1):6. - PMID 33262501

3

Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5) : a randomised, controlled, open-label, phase 3 trial

enthalten in: The Lancet. Oncology | 2017

von Shaw, A. | Kim, T. | Crinò, L. | +17

CommentIn: Lancet Oncol. 2017 Jul;18(7):837-839. - PMID 28602777

4

Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer

enthalten in: Nature genetics | 2016

von Lesseur, C. | Diergaarde, B. | Olshan, A. | +51

5

Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK-Targeted Therapies in Previously Treated Advanced NSCLC : An Adjusted Comparison with External Controls

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2016

von Tan, D. | Araújo, A. | Zhang, J. | +4

6

Lifestyle Behaviors in Elderly Cancer Survivors : A Comparison With Middle-Age Cancer Survivors

enthalten in: Journal of oncology practice | 2015

von Niu, C. | Eng, L. | Qiu, X. | +18

7

Informed genome-wide association analysis with family history as a secondary phenotype identifies novel loci of lung cancer

enthalten in: Genetic epidemiology | 2015

von Poirier, J. | Brennan, P. | McKay, J. | +22

8

Whole-miRNome profiling identifies prognostic serum miRNAs in esophageal adenocarcinoma : the influence of Helicobacter pylori infection status

enthalten in: Carcinogenesis | 2015

von Zhai, R. | Wei, Y. | Su, L. | +4

9

Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma

enthalten in: Carcinogenesis | 2014

von Buas, M. | Levine, D. | Makar, K. | +21

10

Interaction of polymorphisms in mitotic regulator genes with cigarette smoking and pancreatic cancer risk

enthalten in: Molecular carcinogenesis | 2013

von Jang, J. | Cotterchio, M. | Borgida, A. | +3